Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENTRECTINIB vs EPINASTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENTRECTINIB vs EPINASTINE: Safety Overview

Metric ENTRECTINIB EPINASTINE
Total FAERS Reports 1,491 843
Deaths Reported 246 6
Death Rate 16.5% 0.7%
Hospitalizations 316 25
Average Patient Age 59.8 yrs 50.0 yrs
% Female Patients 58.1% 66.9%
FDA Approval Date Aug 15, 2019 Dec 7, 2016
Manufacturer Genentech, Inc. Somerset Therapeutics, LLC
Route ORAL OPHTHALMIC
Marketing Status Prescription Discontinued